NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 82 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $632,000 | -18.3% | 200,000 | 0.0% | 0.38% | -13.3% |
Q2 2023 | $774,000 | +39.7% | 200,000 | 0.0% | 0.44% | +59.7% |
Q1 2023 | $554,000 | +153788.9% | 200,000 | 0.0% | 0.27% | +46.0% |
Q4 2022 | $360 | -99.9% | 200,000 | 0.0% | 0.19% | -15.4% |
Q3 2022 | $424,000 | -21.2% | 200,000 | 0.0% | 0.22% | -16.3% |
Q2 2022 | $538,000 | -38.0% | 200,000 | 0.0% | 0.26% | -18.5% |
Q1 2022 | $868,000 | -16.2% | 200,000 | 0.0% | 0.32% | -15.4% |
Q4 2021 | $1,036,000 | -15.6% | 200,000 | 0.0% | 0.38% | -10.3% |
Q3 2021 | $1,228,000 | -39.2% | 200,000 | 0.0% | 0.43% | -17.2% |
Q2 2021 | $2,020,000 | – | 200,000 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
HILLMAN CO | 200,000 | $632,000 | 0.38% |
Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |